🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

14 recruiting trials

for Mixed Dyslipidemia

A Study of Bempedoic Acid or Its Single-pill Combination Therapy With Ezetimibe in Patients With Primary Hypercholesterolaemia or Mixed Dyslipidaemia NCT07206472n/a38 sites📍 Belo Horizonte📍 Belo Horizonte📍 Belo Horizonte Daiichi Sankyo · Tests: Combination of bempedoic acid and ezetimibe WeArable teChnology daTa driVen digitAl healTh cOachINg (ACTIVATION)- A Mixed-methods Study NCT06752772NA1 site📍 Singapore Alexandra Hospital · Tests: Smart watch, Dashboard with nudging system, Digital Health Coach (DHC) A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia NCT06568471Phase 318 sites📍 Beijing📍 Beijing📍 Beijing Hasten Biopharmaceutical Co., Ltd. · Tests: Lerodalcibep, matching placebo A Study to Evaluate the Efficacy and Safety of AD-218 NCT05400317Phase 31 site📍 Daegu Addpharma Inc. · Tests: AD-218, AD-218A Leqvio rPMS (Regulatory Post-Marketing Surveillance in Korea) NCT06770543n/a4 sites📍 Yangsan📍 Busan📍 Seoul Novartis Pharmaceuticals · Tests: Inclisiran Phase 2 Clinical Study of MWX203 Injection Alone or in Combination With Inclisiran Sodium Injection in Patients With Mixed Dyslipidemia NCT07803822Phase 21 site📍 Beijing Shanghai Minwei Biotechnology Co., Ltd · Tests: MWX203, Inclisiran Sodium Injection, Placebo A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias NCT07491172Phase 117 sites📍 Hialeah📍 Jacksonville📍 Orlando CRISPR Therapeutics AG · Tests: CTX310 A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia NCT07421297Phase 32 sites📍 Beijing📍 Beijing CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · Tests: SYH2053 injection, SYH2053 injection placebo A Study to Compare to PK Characteristics and Safety Profiles Between PA-111 and PA-111A NCT06932705Phase 11 site📍 Seoul Addpharma Inc. · Tests: PA-111, PA-111A Phase 3 Clinical Study Evaluating Efficacy, Safety, and Tolerability of Obicetrapib Vs Bempedoic Acid to Treat Dyslipidemia in Adults With Primary Non-familial Hypercholesterolemia or Mixed Dyslipidemia at High to Very High Cardiovascular Risk, During a Treatment Period of Approximately 84 Days NCT07614958Phase 31 site📍 Stockton-on-Tees A. Menarini International Licensing S.A. · Tests: Obicetrapib 10 mg/Bempedoic Acid Placebo, Bempedoic Acid 180mg/Placebo Obicetrapib A Study of SYH2070 Injection in Participants With Mixed Hyperlipidemia NCT07695597Phase 21 site📍 Hangzhou CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · Tests: SYH2070, Placebo Phase 2 Trial Evaluating the Efficacy and Safety of RBD5044 in Patients With Mixed Dyslipidemia NCT06797401Phase 24 sites📍 Lund📍 Mölndal📍 Stockholm Ribocure Pharmaceuticals AB · Tests: RBD5044, Placebo A Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Pitavastatin/Ezetimib NCT06314919n/a1 site📍 Seoul Boryung Pharmaceutical Co., Ltd Study of ARO-DIMERPA in Adult Participants With Mixed Hyperlipidemia NCT07223658Phase 1, Phase 219 sites📍 Charlestown📍 Morayfield📍 East Melbourne Arrowhead Pharmaceuticals · Tests: ARO-DIMERPA, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy